BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Mesoblast’s Phase III Trial in Children With Acute Graft Versus Host Disease Completes Enrollment

  Top-line results are expected in Q1 2018.

  December 20, 2017

   · 

  5 min read
• Pharm Country

  AzurRx BioPharma Announces Publication of U.S. Patent Application for AZX1101

  AZX1101 is intended to prevent the adverse effects of antibiotics, secondary to their action on the gastrointestinal flora and the selection of resistant bacteria strains.

  December 20, 2017

   · 

  3 min read
• Biotech Bay

  Avinger Receives CE Marking Approval for Next Generation Pantheris Image-Guided Atherectomy Device

  Avinger today announced CE Marking approval for its next generation Pantheris Lumivascular atherectomy system, the first-ever image-guided atherectomy device for the treatment of PAD.

  December 20, 2017

   · 

  3 min read
• Deals

  Eloxx Completes Acquisition Transaction With Sevion Therapeutics

  Eloxx today announced the two companies have completed their previously announced acquisition transaction effective as of December 19, 2017.

  December 20, 2017

   · 

  3 min read
• Business

  Ocugen Expands Focus on Inherited Retinal Disorders by Licensing Novel Modifier Gene Therapy Platform

  Ocugen has obtained an exclusive worldwide license to develop and commercialize future ophthalmology products based on groundbreaking technology from the Schepens Eye Research Institute of Massachusetts Eye and Ear.

  December 20, 2017

   · 

  4 min read
• 

  Business

  TARIS, Bristol-Myers Squibb Ink Phase 1b Collaboration

  In conjunction with this collaboration, Bristol-Myers Squibb also made an equity investment in TARIS.

  December 20, 2017

   · 

  24 min read
• Genetown

  Insulet Corporation to Present at Upcoming Investor Conference on January 9

  Insulet Corporation announced that management will present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco, California on January 9, 2018, at 4:30pm (Pacific Time).

  December 20, 2017

   · 

  2 min read
• BioMidwest

  Life Spine Announces Initial Cases and Multiple Surgeries With the SIMPACT Tri-Fin Sacroiliac Joint Fusion System

  SIMPACT Tri-Fin, which features OSSEO-LOC surface technology, launched November of 2017 and joins Life Spine’s broad portfolio of full procedural solutions.

  December 20, 2017

   · 

  1 min read
• Business

  ImmunoPrecise Adds Scientific Depth to its Board of Directors

  ImmunoPrecise is pleased to announce the appointment of Dr. Robert Burke to the Company’s Board of Directors.

  December 20, 2017

   · 

  4 min read
• Drug Development

  Allergan Release: FDA Accepts NDA for Seysara (Sarecycline) for the Treatment of Moderate to Severe Acne

  Allergan and Paratek Pharma today announced that the FDA has accepted a NDA to review Seysara for the treatment of moderate to severe acne vulgaris in patients 9 years of age and older.

  December 20, 2017

   · 

  8 min read